Yield10 Bioscience Announces First Quarter 2020 Financial Results
May 14, 2020 16:15 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31,...
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulatory Status of its CRISPR Genome-Edited C3007 Trait in Camelina, Paving the Way for U.S. Field Tests
April 27, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results
March 19, 2020 16:04 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended...
Yield10 Bioscience Announces Results of 2019 Field Test Program
March 19, 2020 16:02 ET
|
Yield10 Bioscience, Inc.
-- 2019 Field Test Results Highlight CRISPR Technology Approach to Increase in Oil Content in Oilseed Crops -- Outlines Field Tests Planned for 2020 WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE)...
Excision BioTherapeutics Announces Data Presentation at CROI from IND-Enabling Non-Human Primate studies of EBT-001, supporting a CRISPR Gene Editing Technology for HIV Elimination
March 11, 2020 15:27 ET
|
Excision BioTherapeutics
OAKLAND, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, a private biotechnology company focused on applying CRISPR gene editing to curing viral infectious diseases, today...
Yield10 Bioscience Achieves Key Milestones in Early Development Program in Corn to Evaluate Novel Traits
March 10, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that it achieved key milestones in an early development...
Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests
January 16, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Mice Model Market value to hit $11.7 billion by 2025: Global Market Insights, Inc.
December 17, 2019 19:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Global Mice Model Market is anticipated to surpass USD 11.7 billion by 2025, according to a new research report by Global Market Insights,...
Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc.
December 05, 2019 05:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Global Rat Model Market value is set to surpass USD 1.8 billion by 2025, according to a new research report by Global Market Insights, Inc....
Free Event on Weapons of Mass Destruction in the Digital Age Focuses on the Growing Threat of WMD Terrorism
December 03, 2019 12:48 ET
|
1105 Media Inc
McLean, VA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Public Sector 360, a division of 1105 Media, Inc. and Noblis announce the upcoming event, ‘Weapons of Mass Destruction in the Digital Age.’ The event...